Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging, Multicenter Study of the Efficacy of RWJ-333369 in the Prophylaxis of Migraine

NCT00109083 is registered in ClinicalTrials.gov with SK Life Science, Inc. as lead sponsor.

NCT NCT00109083
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00109083 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging, Multicenter Study of the Efficacy of RWJ-333369 in the Prophylaxis of Migraine
Lead sponsor
SK Life Science, Inc.
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2002
Completion date
February 28, 2006
Enrollment
300
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

migraine headaches